Products & Services
Premium Cannabis Materials for Pharmaceutical Innovation
Specifically cultivated and processed for consistency in cannabinoid and terpene profiles — with the documentation and traceability pharmaceutical manufacturers require before integration into their supply chains.
25 kg
Minimum Order Quantity
24 mo
Shelf Life (per storage spec)
4
Medicinal Strain Profiles
100%
Third-Party Tested Every Batch
Primary Offering
Pharmaceutical-Grade Dried Cannabis Flower
Our primary product: bulk pharmaceutical-grade dried cannabis flower for medicinal product manufacturing, supplied with full documentation.
Bulk Cannabis Flower — Pharmaceutical Raw Material
GMP & GACP Compliant Dried Flower
Every batch undergoes a meticulous curing and drying process to preserve optimal therapeutic compounds while ensuring pharmaceutical-grade purity. Consistent cannabinoid and terpene profiles across production runs are maintained through our standardised cultivation and post-harvest protocols.
GACP Compliant
Third-Party Tested
Full Batch Records
COA Included
Export Documented
THC Content Range
15–28% (strain dependent; up to 30% custom)
CBD Content Range
0.5–15% (strain dependent)
Moisture Content
< 12%
Water Activity
≤ 0.65 Aw
Heavy Metals
ICH Q3D compliant
Microbial Testing
EU/USP standards
Pesticide Residues
Below EU MRLs
Cultivation Method
Hybrid Indoor / Outdoor
Minimum Order Quantity
25 kg per batch
Shelf Life
24 months (per storage spec)
Documentation
COA, Batch Records, Regulatory Package
Medicinal Strains
Four Pharmaceutical-Focused Cannabis Varieties
Each strain selected for specific cannabinoid ratios and targeted therapeutic applications. Custom profile development available for research and formulation partners.
Quality Standard
"Pharmaceutical Raw Materials — Not Wellness Supplements."
Our cannabinoid profiles are developed, tested, and documented to the standards of pharmaceutical manufacturers — ICH Q3D heavy metals, Ph. Eur. microbial limits, and full batch traceability on every shipment.
Custom Products
Tailored to Your Exact Requirements
Beyond standard offerings, HMF Ltd can develop custom cannabis materials for specific research programmes or pharmaceutical formulation needs.
Custom Strain Development
Cultivate specific cannabinoid profiles to meet exact requirements for pharmaceutical applications.
Terpene Profile Engineering
Develop cultivation and post-harvest methods to emphasise specific terpene profiles for entourage-effect formulations.
Custom Quality Parameters
Implement additional testing or quality requirements beyond standard protocols for specific regulatory or research needs.
Development Process
Year-Round Production
Ghana's Climate. Europe's Standards.
Year-round equatorial cultivation cycles at a fraction of European production costs — with zero compromise on pharmaceutical documentation or testing.
365-day cultivation potential — no seasonal shutdowns
Hybrid indoor/outdoor model for quality and scale
Climate-controlled post-harvest storage and processing
Export logistics expertise for EU, Canada, UK, and Australia
Packaging & Logistics
Pharmaceutical-Grade Storage & Supply Chain Integrity
Advanced packaging and cold chain management systems designed to maintain product integrity from our facility to yours — with full documentation throughout.
Storage
Climate-Controlled Storage
Purpose-built facilities maintaining 18–22°C and 55–62% RH. Pharmaceutical-grade containers with 24/7 environmental monitoring. Inventory is tracked and documented by batch throughout storage.
Packaging
Tamper-Proof Multi-Layer Barrier
Multi-layer barrier packaging preventing oxygen penetration, moisture loss, and cannabinoid degradation. Tamper-evident seals, child-resistant features, and nitrogen purging capability for large-volume containers
Cold Chain
Validated Cold Chain Management
Insulated shipping containers validated to maintain specified temperatures for up to 72 hours, with real-time temperature monitoring throughout international transit.
Documentation
Complete Export Documentation
Full chain-of-custody records, temperature monitoring data, COAs, regulatory compliance packages, and customs documentation for EU, Canada, UK, and Australia export procedures.
Options
Bulk & Transport Configurations
Pharmaceutical-grade stainless steel or food-grade plastic containers for large-volume storage; multi-layer barrier bags with tamper-evident seals for transport. All options available with full documentation.
Traceability
Digital Traceability Architecture
End-to-end digital traceability from cultivation input to shipment delivery. Every lot traceable to cultivation date, batch record, input data, and test results — supporting your supplier qualification audit.
Future Capabilities
Expanding to Meet Evolving Pharmaceutical Needs
Current Series A funding will accelerate development of extraction and processing capabilities — expanding our product range beyond dried flower.
Phase 2 Capability
State-of-the-Art Cold Extraction System
Our planned cold extraction system eliminates thermal processing entirely — preserving the full spectrum of bioactive metabolites including cannabinoids and terpenes without heat-induced degradation. This state-of-the-art approach significantly reduces the risk of thermal decomposition of bioactive metabolites, producing extracts of exceptional pharmacological integrity and superior purity profiles for pharmaceutical API production.
Phase 2 Capability
Standardised Liquid Extracts
Development of standardised liquid extract formulations with verified cannabinoid concentrations — enabling direct integration into pharmaceutical liquid formulation manufacturing processes.
Phase 3 Capability
Isolated Cannabinoid APIs
Long-term roadmap to isolated cannabinoid API production — CBD, CBG, and minor cannabinoid isolates produced to pharmacopoeial specifications for direct integration into drug product manufacturing.
Request Full Product Specifications
Complete product data sheets, analytical test results, and regulatory documentation available to qualified partners.